A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

BioChaperone® Combo

Injection of BioChaperone® Combo

DRUG

Humalog® Mix25

Injection of Humalog® Mix25

DRUG

Humalog®

Injection of Humalog®

DRUG

Lantus®

Injection of Lantus®

DRUG

Placebo

Injection of 0.9% NaCl

Trial Locations (2)

Profil GmbH, Neuss

Profil Mainz GmbH & Co.KG, Mainz